Back to calendar
Ligand Pharmaceuticals Incorporated (LGND) Earnings
LGND reports earnings on Thursday, October 29, 2026
earnings report
October 29, 2026
Q3 2026
Est. EPS: $2.87
Actual EPS: $2.67
EPS surprise: 14.66%
Company overview
Market Cap$6.3B
PriceUSD 316.13
P/E141.01
EPS (TTM)2.24
52-week high326.63
52-week low175.89
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees47